Progress Toward Regional Measles Elimination - Worldwide, 2000-2018

MMWR Morb Mortal Wkly Rep. 2019 Dec 6;68(48):1105-1111. doi: 10.15585/mmwr.mm6848a1.

Abstract

In 2010, the World Health Assembly (WHA) set the following three milestones for measles control to be achieved by 2015: 1) increase routine coverage with the first dose of measles-containing vaccine (MCV1) among children aged 1 year to ≥90% at the national level and to ≥80% in every district, 2) reduce global annual measles incidence to less than five cases per 1 million population, and 3) reduce global measles mortality by 95% from the 2000 estimate* (1). In 2012, WHA endorsed the Global Vaccine Action Plan, with the objective of eliminating measles§ in five of the six World Health Organization (WHO) regions by 2020. This report updates a previous report (2) and describes progress toward WHA milestones and regional measles elimination during 2000-2018. During 2000-2018, estimated MCV1 coverage increased globally from 72% to 86%; annual reported measles incidence decreased 66%, from 145 to 49 cases per 1 million population; and annual estimated measles deaths decreased 73%, from 535,600 to 142,300. During 2000-2018, measles vaccination averted an estimated 23.2 million deaths. However, the number of measles cases in 2018 increased 167% globally compared with 2016, and estimated global measles mortality has increased since 2017. To continue progress toward the regional measles elimination targets, resource commitments are needed to strengthen routine immunization systems, close historical immunity gaps, and improve surveillance. To achieve measles elimination, all communities and countries need coordinated efforts aiming to reach ≥95% coverage with 2 doses of measles vaccine (3).

MeSH terms

  • Adolescent
  • Adult
  • Child
  • Child, Preschool
  • Disease Eradication*
  • Global Health / statistics & numerical data*
  • Humans
  • Immunization Programs
  • Incidence
  • Infant
  • Measles / epidemiology
  • Measles / mortality
  • Measles / prevention & control*
  • Measles Vaccine / administration & dosage
  • Young Adult

Substances

  • Measles Vaccine